A healthcare AI strategy is not a list of use cases. It is a set of decisions about where you will lead, where you will follow, what you will refuse, who approves what, and how any of it reaches production.
CaliberFocus helps health systems, hospitals, physician groups and ambulatory organizations get from scattered pilots to a governed portfolio. We start by inventorying the AI already running in your organization, including the models your vendors shipped inside systems you already own, then tier it by risk, assess whether your data and integration foundation can actually carry the roadmap, and stand up governance that returns decisions fast enough that departments stop working around it.
Most organizations do not have an AI problem. They have thirty pilots, no inventory, and no agreed way to say yes.
Almost every provider organization is doing AI. Departments have bought point solutions. Innovation teams are running pilots. The EHR vendor has enabled predictive models. A revenue cycle partner is using AI on your accounts under an existing contract. Somewhere a clinical team is evaluating a tool nobody in IT has heard of.
What is usually missing is a single view of all of it, an agreed basis for choosing between the next twenty requests, and a governance process fast enough that people use it rather than avoid it. The result is familiar: a large number of promising pilots, a small number in production, no reliable way to explain why, and a growing set of AI systems the organization is accountable for but has never assessed.
No inventory of what is already running
Most organizations cannot list their AI systems. You cannot govern, secure or defend a portfolio you cannot enumerate.
Vendor AI is the larger exposure
The models embedded in your EHR, revenue cycle vendor and point solutions are already in production and often unassessed.
Governance built to say no
A committee that only blocks becomes something to route around. Slow review creates invisible AI, not safer AI.
Technology chosen before the problem
The workflow, risk, data and expected outcome should choose the technology, not the other way around.
Ownership that sits between committees
IT, business, clinical leadership, compliance, data and security each hold part of the problem, so issues move between meetings.
A roadmap that is really a wish list
A list without sequencing, readiness gates, funding and owners is not a strategy.
Readiness assumed rather than assessed
Programs commit to ambitious AI without confirming the data, integration or content foundation required.
Value claimed but never measured
Benefits are projected in the business case and rarely reconciled afterward.
The scarce resource is not AI capability. It is the organizational capacity to absorb change.
Strategy is therefore mostly an exercise in choosing, sequencing and stopping, not in identifying opportunity. Opportunity is not scarce. Attention is.
Strategy is therefore mostly an exercise in choosing, sequencing and stopping, not in identifying opportunity. Opportunity is not scarce. Attention is.
We start with what you already have running, what your foundation can carry, and who is entitled to decide. A roadmap produced before those three things are established is a document, not a plan.
Step 1
Inventory
Enumerate every AI system in use or in flight. Built, bought, embedded in vendor products, and in pilot. Including the ones no central function approved.
Step 2
Tier by risk
Classify each system by the consequence of it being wrong. Administrative, operational, clinically adjacent, or clinical decision support.
Step 3
Diagnose the workflow
Map the current process, systems, data, decision points, exceptions, volumes and baseline before recommending anything.
Step 4
Assess readiness
Evaluate the data, integration, security, content and workforce foundation against what the roadmap would require.
Step 5
Build the portfolio
Score candidate use cases on value, feasibility, risk, readiness dependency and organizational appetite, with operational owners in the room.
Step 6
Sequence and stop
Decide what is first, what is a deliberate fast-follower, and what the organization will not pursue. Stopping is a decision with a named owner.
Step 7
Set decision rights
Define who approves what at each risk tier, what evidence they require, and the service level for returning a decision
Step 8
Fund and staff
Agree the funding model, delivery capacity, build versus buy posture and the change capacity available per quarter.
Step 9
Run and re-plan
Operate governance as a standing process. Monitor deployed systems, revalidate on a cycle, and re-plan the portfolio against measured results.
| Element | Typical AI strategy | A usable strategy |
|---|---|---|
| Basis | A list of opportunities | A set of decisions with owners |
| Scope | What we will build | Everything running, including vendor and embedded AI |
| Prioritization | Value versus effort | Value, risk tier, readiness gate and change capacity |
| Stopping | Not addressed | An explicit stop list with reasons |
| Governance | A committee and a policy | Decision rights, evidence requirements and a decision SLA |
| Lifespan | Refreshed annually | Re-planned on a cycle against measured results |
A strategy that never says no is not a strategy.
Stopping, deferring or refusing initiatives releases capacity and makes the remaining sequence credible. On some candidates the honest recommendation is not AI at all.
Stopping, deferring or refusing initiatives releases capacity and makes the remaining sequence credible. On some candidates the honest recommendation is not AI at all.
Strategy work fails when it produces a document nobody is accountable for executing. Every capability below ends in something specific: a register, a tier, a scored portfolio, a decision right, a gate, or a measured result.
Assess and Inventory
AI System Inventory
A complete register covering internally built systems, purchased point solutions, embedded models and pilots.
Vendor and Embedded AI Assessment
Due diligence on what the model does, training and validation, monitoring, contractual liability, and visibility when it is wrong.
Readiness Assessment
Data quality, identity, integration, security, content governance, analytics maturity and workforce capability assessed against the roadmap.
Decide and Prioritize
Use Case Portfolio and Scoring
A consistent model across value, feasibility, risk tier, readiness dependency and organizational appetite.
Build, Buy and Partner Posture
A defensible position by domain on where to differentiate, where to buy and integrate, and where to wait.
Roadmap, Funding and Capacity Model
A sequenced plan constrained by change capacity and delivery capability, with funding, owners and readiness gates.
Govern and Sustain
Governance Operating Model
Committee structure, decision rights by risk tier, intake process, evidence requirements and a published decision service level.
Policy and Risk Framework
AI policy, acceptable use, tiering criteria and oversight requirements aligned to recognized frameworks and existing governance.
Model Lifecycle and Assurance
Approval, deployment, monitoring, revalidation and retirement with post-go-live performance and drift monitoring.
Workforce Enablement and Change
Role-based education, clinical and operational engagement, and honest communication about job impact.
What CaliberFocus does, and does not do?
We are not selling you a framework and leaving. We do the inventory, run vendor assessments, facilitate scoring with operational owners, draft governance into your existing committee structure, and stay through the first cycle of decisions. We also build the systems on the roadmap, which means our recommendations carry the accountability of having to deliver them.
We are not selling you a framework and leaving. We do the inventory, run vendor assessments, facilitate scoring with operational owners, draft governance into your existing committee structure, and stay through the first cycle of decisions. We also build the systems on the roadmap, which means our recommendations carry the accountability of having to deliver them.
The table below is the starting position we bring to a scoring session, not the answer. Your data foundation, your specialty mix and your appetite for clinical risk will move several of these rows. What it does establish is that value, difficulty and risk are three different axes, and that the most valuable domain is rarely the right place to start.
| Domain | Typical value | Difficulty | Risk tier | Usual position |
|---|---|---|---|---|
| Document processing and intake | High | Moderate | Operational | First wave |
| Patient access and contact center | High | Moderate to high | Operational | First wave |
| Revenue cycle automation | High | Moderate | Operational | First wave |
| Ambient clinical documentation | High | Moderate | Clinically adjacent | First wave, one specialty |
| Coding and documentation integrity | High | High | Clinically adjacent | Second wave |
| Quality and regulatory reporting | Moderate | Moderate | Operational | Second wave |
| Supply chain and workforce | Moderate | Moderate | Administrative | Second wave |
| Population health and risk stratification | High | High | Clinically adjacent | Requires data maturity |
| Predictive clinical models | High | High | Clinical decision support | Requires full governance first |
| Diagnostic and treatment AI | High | Very high | Clinical decision support | Regulated pathway, buy do not build |
Scoring produces a ranking. A ranking without decisions is still a backlog. Every use case leaves the session with one of five verdicts and a named owner.
Proceed
Value, readiness and controls justify moving forward now.
Next: fund the gate, not the initiative.
Prepare
Attractive, but a data, integration, content or governance prerequisite is missing.
Next: fund the gate, not the initiative.
Pilot
Genuine uncertainty that a controlled evaluation can resolve.
Next: time-boxed pilot with production path and success criteria agreed first.
Hold
Value or readiness does not currently justify investment.
Next: park with a review date.
Do not pursue
Risk, economics, evidence or organizational fit do not support deployment.
Next: close with a written reason.
Every failed AI program we have reviewed failed on foundation rather than on model performance. The model could not see the data, could not write back, could not be monitored, or answered from content nobody governed. We assess readiness against the specific roadmap you are proposing rather than against a generic maturity curve.
| Domain | What we assess | What it gates |
|---|---|---|
| Data foundation | Identity resolution and patient matching, data quality, terminology and coding consistency, historical depth, lineage | Anything predictive, and any use case where a wrong match is a safety event |
| Integration capacity | FHIR and API maturity, interface engine capacity, write-back capability, vendor app frameworks, delivery bandwidth | Ambient documentation, agents, conversational AI. Almost everything |
| Content governance | Document ownership, effective dating, version control, retirement process, permission hygiene | Copilots and any retrieval based system |
| Security and identity | Enterprise identity, role based access, permission review posture, logging and monitoring maturity | Any system touching PHI, which is most of them |
| Platform and environments | Model hosting, sandbox and evaluation environments, deployment pipeline, portability across providers | Anything that needs to be tested before it reaches patients or staff |
| Monitoring and assurance | Evaluation capability, drift detection, incident process, revalidation cadence | Every system in a clinically adjacent tier or above |
| Workforce and change | Adoption capacity by department, clinical engagement, training capability, change saturation | The realistic pace of the whole roadmap |
Readiness gates, not readiness scores
A maturity score tells you how you compare to a benchmark. A gate tells you whether a specific initiative can proceed. If a gate is not met, fund the gate rather than the initiative.
A maturity score tells you how you compare to a benchmark. A gate tells you whether a specific initiative can proceed. If a gate is not met, fund the gate rather than the initiative.
Portability over commitment
Architect so model and platform choices can change.
Systems of record stay where they are
AI is a layer over clinical and operational systems, not a new store of truth.
Build the evaluation environment first
Testing, measurement and rollback are infrastructure.
One integration and identity approach
Avoid nine AI systems with nine security postures.
Plenty of tools will read a document and give you structured data back. The saving only arrives when that data reaches the chart, the queue and the workflow without a person moving it. Filing correctly is a deeper integration problem than extraction, and it is where these programs are won or lost.
Correct chart destination
The right patient, the right encounter, the right document type and the right chart location, resolved automatically and confirmed before filing.
The image and the data together
The source document is filed alongside the discrete data extracted from it, so a clinician can always see the original.
Downstream workflow triggering
Filing is not the end. The referral is created, the ordering clinician is notified, the denial is routed, the request is queued.
Sender feedback loop
Where a sender consistently transmits incomplete or unreadable documents, that pattern is surfaced so it can be fixed at source rather than absorbed forever.
One audit trail
Every document, every extracted value, every correction and every filing action logged in one place, linked to the source image.
Graceful degradation
If a downstream system is unavailable, documents queue safely with their processing intact rather than failing or filing into the wrong place.
EHR and practice management
Patient and encounter matching, chart filing, note type mapping, discrete data write back
Document management and content platforms
Storage, retention, versioning and retrieval within your existing repository
Fax and secure transmission platforms
Digital fax, Direct messaging, secure email and health information exchange intake
Scanning and capture infrastructure
Front desk and back office scanning brought into the same pipeline
Integration engine
Routing and transformation kept on your governed interface layer
Clearinghouse and revenue cycle systems
Remittance, correspondence and authorization document flow
FHIR and vendor APIs
Structured write back of results, orders and observations where supported
Data and analytics platforms
Straight through rate, accuracy and backlog measurement
The EHR and your document repository remain the record. Document AI is a processing layer in front of them, not a parallel store of clinical documents. Retention, legal medical record definition and disclosure governance stay exactly where they already sit.
PHASE 1
Document mix assessment
2 to 3 weeks
Volume and channel analysis by document type, sample review against real inbound documents, baseline turnaround and touch counts captured.
PHASE 2
Build and calibrate
4 to 6 weeks
Pipeline built, classification and extraction configured, matching and validation logic implemented, gold standard test set created with your HIM team.
PHASE 3
Shadow and pilot
3 to 4 weeks
Runs in parallel on live volume. Field level accuracy measured against human decisions. Thresholds set from real data before any automatic filing
PHASE 4
Production and scale
Ongoing
Straight through rate raised in steps against measured accuracy. Monitoring by type and sender, and expansion to the next document type.
PHASE 1
Opportunity assessment
2–3 weeks
Recognizes a request, document, message, work item or system event.
PHASE 2
Design & build
4–6 weeks
Interprets structured and unstructured information and establishes context.
PHASE 3
Shadow & pilot
2–3 weeks
Recognizes a request, document, message, work item or system event.
PHASE 4
Production & scale
Ongoing
Recognizes a request, document, message, work item or system event.
Governance that only blocks gets routed around, and the traffic does not stop, it just becomes invisible. The objective is a process that returns a clear decision quickly, applies oversight proportionate to consequence, and makes the compliant path the fast path. That means tiering by risk rather than reviewing everything to the same depth.
| Risk tier | Examples | Oversight required | Decision authority |
|---|---|---|---|
| Administrative | Internal drafting, meeting summarization, IT and HR knowledge assistance | Acceptable use policy, logging, named owner | Delegated, registered not reviewed |
| Operational | Document intake, scheduling, claim status, patient access conversation, revenue cycle agents | Accuracy evaluation, human exception handling, monitoring, escalation. Where the system executes transactions: explicit permissions, transaction limits, confirmation, rollback and audit log | AI governance function |
| Clinically adjacent | Ambient documentation, coding support, care gap identification, clinical knowledge retrieval | Clinical sign off, pre-deployment validation, sampled review, revalidation cycle | Clinical leadership plus governance |
| Clinical decision support | Risk stratification, deterioration prediction, triage, treatment or diagnostic recommendation | Full validation on local population, bias assessment, transparency disclosure, formal monitoring | Committee with clinical, legal and compliance |
| Autonomous clinical decision | Any system acting on a clinical decision without a clinician. | Not offered. | Never |
A published decision service level
Tier one registers in days. Tier two returns a decision in a stated window. Higher tiers have a scheduled review cadence
Conditional approval as the default
Most decisions should be yes with conditions and a review date, not a binary.
Evidence requirements stated in advance
Teams know what validation, monitoring plan and owner they must bring before they apply.
Vendor AI enters the same process
Purchased and embedded AI is tiered and reviewed on the same criteria as internally built systems.
Post-deployment is where governance lives
Monitoring, revalidation, drift response and retirement need a named owner per system.
An incident route clinicians will use
Low-friction reporting, triage, root cause and feedback loop to the owning team.
Shadow AI is a governance design failure, not a discipline failure.
When staff use unapproved tools, the usual cause is that the approved path was slower than the deadline they were working to. Measure your decision turnaround before you measure policy compliance, because the first number explains the second.
Healthcare AI regulation is developing across several authorities at once, at different speeds, with real disagreement between jurisdictions. Building a framework tied to any single current requirement guarantees rework. We align to established, durable frameworks and map specific obligations onto them, so a new state law becomes a mapping exercise rather than a rebuild.
Framework
alignment
- Alignment to recognized AI risk management and management system frameworks rather than to a bespoke internal model
- Obligations mapped onto that framework, so new requirements are absorbed rather than triggering a rewrite
- Delivery into your existing enterprise risk, clinical governance and vendor management structures rather than beside them
- A defensible written record of how each system was assessed, by whom, and against what criteria
Regulatory
landscape
- Transparency and source attribute obligations for predictive decision support in certified health IT
- The boundary between clinical decision support and regulated medical device software, assessed per use case
- Nondiscrimination obligations relating to clinical algorithms and patient care decision support tools
- Requirements governing algorithms used in coverage, utilization management and benefit determination
- State AI, privacy, disclosure and consent law across your operating footprint, plus HIPAA and HITECH throughout
- Regulatory classification assessed on intended use and function. Calling something a copilot does not remove an obligation that attaches to what it actually does
Fairness & clinical
safety
- Bias and equity assessment for any system that prioritizes, ranks, scores or targets patients
- Validation on your own population rather than acceptance of a vendor performance claim
- Clinician and patient transparency about where AI is in use and what it does
- Ongoing performance monitoring by subgroup, because a model that was fair at deployment may not stay fair
- Explainability calibrated to the use case. A copilot needs source citations, a predictive model needs feature and performance documentation, an agent needs a complete action log
Security & vendor
risk
- AI systems assessed within your existing security review, with model specific risks added rather than substituted
- Prompt injection, data poisoning and unintended disclosure tested where retrieval or agentic behavior is involved
- Vendor AI assessed on a standing checklist: data handling, subprocessors, training data terms, model transparency, evaluation evidence, update and release practice, incident notification, auditability, liability and exit portability
- Data flow mapping for every system, including where inference happens and what leaves your environment
The question to ask a vendor is not whether their model is accurate. It is what happens when it is wrong.
How will you know, how quickly, what will you see, who is liable, and what recourse do you have. Most AI procurement conversations never reach those four questions, and they are the ones that matter when the system is in production and something has gone wrong.
How will you know, how quickly, what will you see, who is liable, and what recourse do you have. Most AI procurement conversations never reach those four questions, and they are the ones that matter when the system is in production and something has gone wrong.
A strategy engagement should change what the organization does, not add a document to a shared drive. These are the measures that show whether it did.
| Category | What we measure | Why it matters |
|---|---|---|
| Portfolio throughput | Initiatives reaching production, time from approval to production, share of AI spend on systems in production | The pilot to production gap, made visible |
| Governance velocity | Decision turnaround against the published service level, share of decisions that are conditional approvals rather than refusals | Predicts whether the process gets used or avoided |
| Inventory completeness | Share of AI systems registered, share of vendor and embedded AI assessed, systems overdue revalidation | You cannot govern what you have not enumerated |
| Value realization | Benefits realized against business case, by initiative, reconciled rather than projected | Determines whether the second wave gets funded |
| Risk position | Incidents and time to detection, models in production without a named owner, unapproved tool use | The board and audit view |
| Capacity | Change capacity consumed against available, initiatives deferred deliberately rather than stalled | Whether the plan matched the organization |
The most common first-year result is a smaller portfolio.
A shorter vendor list, several initiatives stopped, and a governance process that returns decisions in days are real outcomes. Agree in advance that stopping things counts as progress.
A shorter vendor list, several initiatives stopped, and a governance process that returns decisions in days are real outcomes. Agree in advance that stopping things counts as progress.
If the answer is uncertain, that is the engagement. We will inventory what is running including vendor and embedded AI, tier it by risk, assess your foundation against what you are proposing to build, score the portfolio with your operational owners, and give you a sequenced roadmap with an explicit stop list and a governance model that fits the committee structure you already have. If the honest finding is that readiness work must come before any new initiative, we will say so and scope that instead.
Bring us a specialty or clinical setting where clinicians are spending too much time creating notes. We will assess where ambient documentation fits, what must remain clinician controlled, how it should integrate with your EHR, and how to measure whether it is actually reducing burden.
One conversation with people who have run these deployments, and a written readiness view you can use with or without us.
- AI Agents and Workflow Automation
- Voice and Conversational AI
- Document AI and Intelligent Processing
- Generative AI and Enterprise Copilots
- AI Strategy and Governance
- HCC and Risk Adjustment Analytics
Security & Compliance
